Update on supportive care and new therapies: immunomodulatory drugs, growth factors and epigenetic-acting agents.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2005, Pages 161-166

  Hellström Lindberg, Eva ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CYCLOSPORIN; DRUG DERIVATIVE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH PROMOTOR; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; LENALIDOMIDE; LYMPHOCYTE ANTIBODY; THALIDOMIDE;

ARTICLE; BLOOD TRANSFUSION; GENETICS; HUMAN; METABOLISM; MYELODYSPLASTIC SYNDROME; QUALITY OF LIFE; RISK ASSESSMENT;

ANGIOGENESIS INHIBITORS; ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; CYCLOSPORINE; GRANULOCYTE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HEMOGLOBINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYELODYSPLASTIC SYNDROMES; QUALITY OF LIFE; RISK ASSESSMENT; THALIDOMIDE;

EID: 33744823744     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2005.1.161     Document Type: Article

References (0)